RecruitingNCT06852378

Iliopsoas Nerve Block and Femoral Nerve Block in Hip Fracture Surgeries

Comparison Between Iliopsoas Nerve Block and Femoral Nerve Block in Hip Fracture Surgeries


Sponsor

Ain Shams University

Enrollment

80 participants

Start Date

Mar 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to compare iliopsoas nerve Block (IPB) to femoral nerve block (FNB) regarding pain control, patient satisfaction, and early ambulation in patients undergoing hip fracture surgeries


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria4

  • Age from 18 to 65 years.
  • Both sexes.
  • American Society of Anesthesiologists (ASA) physical status I and II.
  • Patients who are scheduled for elective surgical correction of hip fracture either through open fracture internal fixation (ORIF), partial hip arthroplasty or total hip arthroplasty.

Exclusion Criteria4

  • Refusal to participate.
  • Coagulopathy.
  • Patients with a history of drug allergies to study drugs.
  • Inability to cooperate.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGIliopsoas nerve block

Patients will receive an Iliopsoas nerve block using 10 ml of bupivacaine 0.5%.

DRUGFemoral nerve block

Patients will receive femoral nerve block using 10 ml of bupivacaine 0.5%.


Locations(1)

Ain Shams University

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06852378


Related Trials